Skip to main content

Table 1 Demographics and clinical characteristics of study cohort

From: Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes

Characteristics

Non-LLT Group

LLT Group

p-value

PS adjusted Non-LLT

PS adjusted

LLT

p-value

Age(years), Mean [SD]

65.5(12.1)

66.4(10.7)

0.231

66.4(11.3)

66.0(10.8)

0.394

Female, N (%)

225(29.5)

778(24.1)

0.003

1060(26.1)

1002(25.2)

0.637

BMI, Mean [SD]

28.7(8.4)

29.5(7.5)

0.007

29.1(5.9)

29.2(5.9)

0.778

Diabetes, N (%)

231(30.2)

1361(42.2)

 < 0.001

1675(41.3)

1593(40.0)

0.591

Renal Failure, N (%)

47(6.2)

169(5.2)

0.363

211(5.2)

214(5.4)

0.861

Dialysis, N (%)

32(4.2)

120(3.7)

0.617

151(3.7)

151(3.8)

0.943

Hypertension, N (%)

556(72.8)

2755(85.5)

 < 0.001

3378(83.3)

3308(83.1)

0.896

Smoking, N (%)

359(47.0)

1645(51.0)

0.049

2025(49.9)

1993(50.0)

0.957

Chronic lung disease, N (%)

132(17.3)

532(16.5)

0.643

631(15.6)

660(16.6)

0.539

Peripheral arterial disease, N (%)

87(11.4)

497(15.4)

0.006

636(15.7)

584(14.7)

0.593

Cerebrovascular disease, N (%)

91(11.9)

587(18.2)

 < 0.001

720(17.8)

678(17.0)

0.717

Creatinine, Mean [SD]

1.26(1.16)

1.23(1.04)

0.523

1.24(1.06)

1.23(1.07)

0.885

Previous cardiac surgery, N (%)

17(2.2)

139(4.3)

0.010

177(4.4)

157(3.9)

0.718

Previous MI, N (%)

253(33.1)

1482(46.0)

 < 0.001

1763(43.4)

1728(43.4)

0.985

Previous heart failure, N (%)

206(27.0)

811(25.2)

0.325

1007(24.8)

1009(25.3)

0.792

Cardiogenic shock, N (%)

25(3.3)

51(1.6)

0.003

75(1.8)

75(1.9)

0.942

ACEI. ARB treatment, N (%)

297(38.9)

1568(48.6)

 < 0.001

1986(48.9)

1872(47.0)

0.410

Aspirin treatment, N (%)

547(71.6)

2853(88.5)

 < 0.001

3500(86.3)

3403(85.5)

0.519

β-blocker treatment, N (%)

485(63.5)

2573(79.8)

 < 0.001

3136(77.3)

3058(76.8)

0.776

EF < , Mean [SD]

50.2(14.49)

51.03(13.62)

0.132

51.1(13.3)

50.9(13.8)

0.719

Valve procedure, N (%)

239(31.3)

705(21.9)

 < 0.001

911(22.4)

938.2(23.6)

0.536

Other cardiac surgery, N (%)

85(11.1)

273(8.5)

0.025

325(8.0)

353(8.9)

0.449

CPB time, Mean [SD]

136.7(78.9)

132.0(71.4)

0.109

134.2(76.6)

132.7(72.1)

0.685

Clamp time, Mean [SD]

97.6(61.8)

92.7(54.5)

0.028

94.8(61.2)

93.2(54.9)

0.583

  1. LLT lipid lowing treatment, N numbers, SD standard deviation, BMI body mass index, MI myocardial infarction, EF ejection fraction, CPB cardiopulmonary bypass, DC-lipid lowering discharge with lipid lowering medications, PS propensity score